CTT Pharmaceutical Holdings, Inc.
CTTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001035422
In the last 90 days, CTT Pharmaceutical Holdings, Inc. insiders filed 11 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $3.79K in total
- 11
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding CTTH, Q2 2026
No superinvestor reported holding CTTH at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by CTT Pharmaceutical Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 (view filing)10:15 AM ET | Sep 22 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +10.1K | $0.045 | +$454.5 | +1.0%1.06M after | |
| Sep 16, 2026 (view filing)1:19 PM ET | Sep 16 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +10.9K | $0.048 | +$523.2 | +0.1%9.41M after | |
| Sep 10, 2026 (view filing)6:10 PM ET | Sep 10 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +3.50K | $0.05 | +$175 | 0.0%9.40M after | |
| Sep 4, 2026 (view filing)4:18 PM ET | Sep 4 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +9.80K | $0.0489 | +$479.22 | +0.1%9.40M after | |
| Sep 2, 2026 (view filing)2:33 PM ET | Sep 2 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +3.00K | $0.0489 | +$146.7 | 0.0%9.39M after | |
| Aug 31, 2026 (view filing)2:12 PM ET | Aug 31 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +3.50K | $0.049 | +$171.5 | 0.0%9.38M after | |
| Aug 24, 2026 (view filing)9:02 PM ET | Aug 24 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +2.10K | $0.055 | +$115.5 | 0.0%9.36M after | |
| Aug 20, 2026 (view filing)10:11 AM ET | Aug 20 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +11.5K | $0.045 | +$517.5 | +0.1%9.38M after | |
| Aug 19, 2026 (view filing)10:28 AM ET | Aug 19 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +10.0K | $0.059 | +$590 | +0.1%9.37M after | |
| Aug 14, 2026 (view filing)5:24 PM ET | Aug 14 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +1.80K | $0.062 | +$111.6 | 0.0%9.36M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in CTT Pharmaceutical Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding CTTH in 13F filings for Q2 2026.